“Minimizing the daily steroid use of systemic lupus erythematosus patients while concomitantly controlling their disease activity may reduce the looming economic burden associated with corticosteroid use,” said Shaum Kabadi, PhD, and colleagues.

The researchers observed that previous studies of dermatologic diseases have shown a much higher prevalence of depression in patients with CLE—in some cases double or triple that of the general population.

Results 1 - 2 of 2
  • American Health and Drug Benefits
  • Lynx CME
  • Value Based Care in Rheumatology
  • Oncology Practice Management
  • Urology Practice Management